News
The CBI had claimed the circulars were meant to keep a watch on the Roys. The Delhi High Court has told the CBI that it would ...
Quarterly Net Profit at Rs. 16.29 crore in March 2025 down 3.92% from Rs. 16.95 crore in March 2024. EBITDA stands at Rs.
Windlas Biotech Ltd has lost 9.89% over last one month compared to 1.44% fall in BSE Healthcare index and 1.1% rise in the SENSEX ...
1h
Stocktwits on MSNRetail Bulls Cheer Imunon’s Pullback From Public Offering, Citing ‘Much Better Funding Options’Retail buzz around Imunon rose sharply Thursday after the clinical-stage biotech company said it will no longer pursue a ...
The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...
The Colorado Bureau of Investigation is looking for a teen from Center, Colorado, located in the San Luis Valley, who was not returned to her parents.
Jefferies is acting as lead book-running manager for the offering and H.C. Wainwright & Co. is acting as co-manager for the offering. Gyre intends to use the net proceeds from this offering, together ...
President Trump on Thursday claimed his recent “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in just a matter of weeks, saying ...
Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced seven upcoming poster presentations at the 2025 American Society of ...
ABOUT CARVYKTI® (CILTACABTAGENE AUTOLEUCEL; CILTA-CEL) ...
Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ongoing, first-in-human Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results